#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3818	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2643	427.2	0	.	n	.	0	C207T	SNP	207	207	C	686	686	T	527	T,C,A	329,142,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3818	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2643	427.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1663	1663	C	514	C	465	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5864	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4029	434.3	0	.	n	.	0	T695C	SNP	695	695	T	1113	1113	C	495	C,G	442,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5864	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4029	434.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	2056	2056	G	512	G	469	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5864	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4029	434.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2389	2389	C	523	C,A	469,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5864	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4029	434.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2463	2463	A	509	A,C,G	456,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5864	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4029	434.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3015	3015	C	520	C,T,G	201,268,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	570	folP	855	855	100.0	folP.l6.c4.ctg.1	2033	83.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1239	1241	AGC	137;137;138	A;G;C	123;123;126	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1108	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3983	83.4	1	SNP	p	S91F	1	.	.	271	273	TTC	894	896	TTC	103;102;102	T,G;T,G;C,G	86,1;94,1;88,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1108	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3983	83.4	1	SNP	p	D95G	1	.	.	283	285	GGC	906	908	GGC	99;99;99	G;G;C	87;91;88	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1108	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3983	83.4	1	SNP	p	G95N	0	.	.	283	285	GGC	906	908	GGC	99;99;99	G;G;C	87;91;88	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	586	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1913	92.0	1	SNP	p	G45D	0	.	.	133	135	GGC	779	781	GGC	153;155;156	G,T;G;C	136,1;140;139	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	372	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1501	74.5	0	.	n	.	0	A197.	DEL	197	197	A	897	897	A	132	A	126	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1246	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3602	103.7	1	SNP	p	D86N	0	.	.	256	258	GAC	879	881	GAC	133;133;133	G;A;C	115;110;119	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1246	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3602	103.7	1	SNP	p	S87R	1	.	.	259	261	CGT	882	884	CGT	133;134;132	C;G;T	118;119;115	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1246	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3602	103.7	1	SNP	p	R87I	0	.	.	259	261	CGT	882	884	CGT	133;134;132	C;G;T	118;119;115	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1246	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3602	103.7	1	SNP	p	R87W	0	.	.	259	261	CGT	882	884	CGT	133;134;132	C;G;T	118;119;115	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1246	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3602	103.7	1	SNP	p	S88P	0	.	.	262	264	TCC	885	887	TCC	132;132;132	T;C,A;C	119;117,1;118	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1074	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3036	105.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1778	1780	GGC	127;126;127	G;G;C	116;112;111	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	1010	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2806	107.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1459	1461	GCC	151;152;152	G;C;C	139;135;138	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1010	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2806	107.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1462	1464	ATG	152;152;151	A;T;G	140;136;135	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1010	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2806	107.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1474	1476	ACC	155;156;155	A;C;C	141;139;137	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1010	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2806	107.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1474	1476	ACC	155;156;155	A;C;C	141;139;137	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1010	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2806	107.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1975	1977	ACC	151;151;150	A;C;C	139;131;133	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1010	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2806	107.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2029	2031	GCG	151;151;151	G;C;G	128;124;125	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1010	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2806	107.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2029	2031	GCG	151;151;151	G;C;G	128;124;125	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1010	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2806	107.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2152	2154	GGT	140;141;141	G;G;T	128;130;129	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1010	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2806	107.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2161	2163	AGC	142;142;143	A;G;C	130;128;129	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1010	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2806	107.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2179	2181	CCG	142;142;140	C;C;G	126;127;121	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1238	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3299	111.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1737	1739	CCG	130;131;131	C;C;G	112;117;114	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	626	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2324	80.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	798	798	C	102	C	96	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	108	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1703	18.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1429	1431	AAT	11;11;11	A;A;T	11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	108	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1703	18.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1432	1434	AAT	11;11;11	A;A;T	11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	108	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1703	18.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1456	1458	GCA	11;11;11	G;C;A	11;10;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	108	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1703	18.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1479	1481	GTA	10;10;10	G;T;A	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	108	porB1a	984	297	91.03	porB1a.l15.c4.ctg.1	1703	18.3	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1488	1488	A	9	A	9	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	734	porB1b	1038	1038	99.9	porB1b.l6.c30.ctg.1	2415	90.2	0	.	p	.	0	I45V	NONSYN	133	135	ATT	653	655	GTT	149;149;149	G;T;T,G	129;129;123,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	734	porB1b	1038	1038	99.9	porB1b.l6.c30.ctg.1	2415	90.2	1	SNP	p	G120K	1	.	.	358	360	AAG	878	880	AAG	155;155;155	A;A;G,A	143;145;143,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	734	porB1b	1038	1038	99.9	porB1b.l6.c30.ctg.1	2415	90.2	1	SNP	p	N121D	0	.	.	361	363	AAC	881	883	AAC	157;156;157	A;A,T;C	144;143,1;144	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	734	porB1b	1038	1038	99.9	porB1b.l6.c30.ctg.1	2415	90.2	1	SNP	p	A121N	1	.	.	361	363	AAC	881	883	AAC	157;156;157	A;A,T;C	144;143,1;144	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2436	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5479	133.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	378	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1561	72.4	1	SNP	p	V57M	1	.	.	169	171	ATG	853	855	ATG	148;148;148	A,C;T;G	134,1;136;134	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
